1.Clinical observation of nicorandil in treatment of 85 patients with angina pectoris
Yuehong CHEN ; Bingzhong CHEN ; Hai LIN
Chinese Journal of Primary Medicine and Pharmacy 2011;18(4):464-465
ObjectiveTo observe the therapeutic effect of nicorandil in treatment of angina pectoris. Methods155 cases of angina pectoris patients were randomly divided into the therapeutic group(85 cases)and control group(70 cases),both of which took normal doses of aspirin vitamin C effervescent tablets 0.1g/day,clopidogrel 50mg/day,elantan 50mg/day and simvastatin 40mg/day,where hypertensions or diabetics were given blood pressure and sugar control and heart failure patients were given proper diuretic therapy and other methods to release heart Ioad.Patients in the therapeutic group were additionally given 5 mg nicorandil,3 times/day.The two groups were both given one period of treatment about one month. ResultsIn therapeutic group,32 cases had significant therapeutic effectiveness,34 cases had effectiveness and 14 cases had no effectiveness with a total effective rate of 82.5%.In the control group,23 cases had significant therapeutic effectiveness,28 cases had effectiveness and 24 cases had no effectiveness with a total effective rate of 67.0%.The comparative difference of the total effectiveness of the twogroups had statistical significance(x2 =4.40,P<0.05).No other significant adverse reaction was found except several cases of light dizzy in the two groups. ConclusionNicorandil has good therapeutic effective in treatment of angina pectoris and no significant adverse reaction.
2.Primary clear cell carcinoma of the cervix:report of five cases and review of the literature
Yuting TAN ; Xin ZHANG ; Zhongqiu LIN ; Qing CHEN ; Lijuan WANG ; Bingzhong ZHANG
Chinese Journal of Obstetrics and Gynecology 2008;43(2):120-123
Objective To review the survival outcomes in patients with endometrial stromal sarcoma(ESS)in Cancer Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,and to discuss prognostic factors and the role of post-operative adjuvant radiotherapy and chemotherapy.Methods Hospital records and pathology reports for 97 patients with ESS were reviewed.Among 97 patients,69 had low-grade ESS(LGESS),16 had high-grade ESS(HGESS)and 12 had unclear grade.The median age at diagnosis was 44.0 years.The median follow-up time was 62 months(5-277 months).Atypical vaginal bleeding(43%)and prolonged and increased menses(36%)were the main symptoms.Results Totally 2-year and 5-year cumulative survival rates were 93%and 84%,respectively.Cumulative survival curves were significantly different between LGESS and HGESS,and so did cumulative survival curves between stage Ⅰ-Ⅱ and stage Ⅲ-Ⅳ(P<0.05).Totally,34 patients(37%)had local or distant recurrence.The median time-to-recurrence(TTR)was 27 months.The recurrence rates of the patients with or without preserve of ovary were 89%and 24%,respectively(P=0.000).The local-control-rates of the patients who received or did not receive post-operative radiotherapy were 81%and 43%,respectively(P=0.011).Conclusions The prognosis of HGESS is obviously worse than that of LGESS.The risk of recurrence of patients with preserve of ovary was remarkably higher than that of patients without preserve of ovary.Postoperative radiotherapy could increase the local-control-rates.